Elevance Health Inc. (ELV) Stock Price: $424.43+6.28 (+1.50%)
The total return cagr for Elevance Health Inc. (ELV) stock is 11.28% over the past 12 months. The 3 year average growth rate is -1.89% and the 5 year cagr is 3.31%. Total return includes dividends reinvested.
The closing share price for Elevance Health Inc. (ELV) stock was $424.43 for Tuesday, June 9, 2026, up +1.50% from the previous day.
ELV Price Chart
ELV Key Metrics
See All MetricsELV Earnings Preview
Next Earnings Date
Jul 16, 2026
37 days away
EPS Estimate
6.20
Revenue Est.
$48.80B
Last Quarter Results
EPS
$12.58
vs Estimate
$10.81
Revenue
$49.49B
vs Estimate
$48.20B
ELV Analyst Ratings
Consensus Rating
Based on 21 analysts
Average Price Target
$415.81
-2.0% downside
Low
$331.00
Current
$424.43
High
$498.00
ELV Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $12.07 | N/A | 8 |
| Q2 2027 | N/A | $7.17 | N/A | 8 |
| Q3 2027 | N/A | $6.09 | N/A | 13 |
| Q4 2027 | N/A | $4.00 | N/A | 8 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $29.24 | N/A | 16 |
| FY 2028 | N/A | $34.09 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $49.67B | N/A | 8 |
| Q2 2027 | N/A | $49.64B | N/A | 8 |
| Q3 2027 | N/A | $50.16B | N/A | 13 |
| Q4 2027 | N/A | $49.63B | N/A | 8 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $199.72B | N/A | 16 |
| FY 2028 | N/A | $210.04B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
ELV Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1ELV | $92.17B | $424.43 | +1.50% | +11.28% | +3.31% | +13.76% |
ELV Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux